TY - JOUR
T1 - Treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults
T2 - Synopsis of the 2013 American college of cardiology/American heart association cholesterol guideline
AU - Collaborators
AU - Stone, Neil J.
AU - Robinson, Jennifer G.
AU - Lichtenstein, Alice H.
AU - Goff, David C.
AU - Lloyd-Jones, Donald M.
AU - Smith, Sidney C.
AU - Blum, Conrad
AU - Schwartz, J. Sanford
AU - Stone, N. J.
AU - Robinson, J. G.
AU - Lichtenstein, A. H.
AU - Lloyd-Jones, D. M.
AU - Eckel, R. H.
AU - Merz, C. N.
AU - Bloom, C. B.
AU - Goldberg, A. C.
AU - Gordon, D.
AU - Levy, D.
AU - McBride, P.
AU - Schwartz, J. S.
AU - Shero, S. T.
AU - Watson, K.
AU - Wilson, P. W.
PY - 2014/3/4
Y1 - 2014/3/4
N2 - Description: In November 2013, the American College of Cardiology and American Heart Association (ACC/AHA) released a clinical practice guideline on the treatment of blood cholesterol to reduce cardiovascular risk in adults. This synopsis summarizes the major recommendations. Methods: In 2008, the National Heart, Lung, and Blood Institute convened the Adult Treatment Panel (ATP) IV to update the 2001 ATP-III cholesterol guidelines using a rigorous process to systematically review randomized, controlled trials (RCTs) and meta-analyses of RCTs that examined cardiovascular outcomes. The panel commissioned independent systematic evidence reviews on low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol goals in secondary and primary prevention and the effect of lipid drugs on atherosclerotic cardiovascular disease events and adverse effects. In September 2013, the panel's draft recommendations were transitioned to the ACC/AHA. Recommendations: This synopsis summarizes key features of the guidelines in 8 areas: lifestyle, groups shown to benefit from statins, statin safety, decision making, estimation of cardiovascular disease risk, intensity of statin therapy, treatment targets, and monitoring of statin therapy.
AB - Description: In November 2013, the American College of Cardiology and American Heart Association (ACC/AHA) released a clinical practice guideline on the treatment of blood cholesterol to reduce cardiovascular risk in adults. This synopsis summarizes the major recommendations. Methods: In 2008, the National Heart, Lung, and Blood Institute convened the Adult Treatment Panel (ATP) IV to update the 2001 ATP-III cholesterol guidelines using a rigorous process to systematically review randomized, controlled trials (RCTs) and meta-analyses of RCTs that examined cardiovascular outcomes. The panel commissioned independent systematic evidence reviews on low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol goals in secondary and primary prevention and the effect of lipid drugs on atherosclerotic cardiovascular disease events and adverse effects. In September 2013, the panel's draft recommendations were transitioned to the ACC/AHA. Recommendations: This synopsis summarizes key features of the guidelines in 8 areas: lifestyle, groups shown to benefit from statins, statin safety, decision making, estimation of cardiovascular disease risk, intensity of statin therapy, treatment targets, and monitoring of statin therapy.
UR - http://www.scopus.com/inward/record.url?scp=84895794526&partnerID=8YFLogxK
U2 - 10.7326/m14-0126
DO - 10.7326/m14-0126
M3 - Article
C2 - 24474185
AN - SCOPUS:84895794526
SN - 0003-4819
VL - 160
SP - 339
EP - 343
JO - Annals of internal medicine
JF - Annals of internal medicine
IS - 5
ER -